6 полученные результаты
TECHNICAL FIELD
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-thiophene compounds that, inter alia, inhibit 11.beta.-hydroxysteroid dehydrogenase type 1 (11.beta.-HSD1). The present invention also
TECHNICAL FIELD
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-thiophene compounds that, inter alia, inhibit 11.beta.-hydroxysteroid dehydrogenase type 1 (11.beta.-HSD1). The present invention also
TECHNICAL FIELD
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-thiophene compounds that, inter alia, inhibit 11.beta.-hydroxysteroid dehydrogenase type 1 (11.beta.-HSD1). The present invention also
BACKGROUND OF THE INVENTION
The value of naturally occurring estrogens and synthetic compositions demonstrating "estrogenic" activity has been in their medical and therapeutic uses. A traditional listing of the therapeutic applications for estrogens alone or in combination with other active agents
CROSS REFERENCE TO RELATED APPLICATION
This application is a National Stage of International Application No. PCT/KR2009/005856 filed Oct. 13, 2009, claiming priority based on Korean Patent Application No. 10-2008-100221, filed Oct. 13, 2008, the contents of all of which are incorporated herein by
TECHNICAL FIELD
The present invention relates to novel aromatic ring fused pyrimidine derivatives or pharmaceutically acceptable salts thereof useful as drugs, particularly as insulin secretagogues or diabetic therapeutic agents, and to a drug comprising these compounds as active